Shenzhen Hepalink Pharmaceutical Group Co., Ltd. announced Poll Results of the 2022 Annual General Meeting Held on May 22, 2023 approved For the purpose of payment of dividend to the holders of the Company's H Shares for the year ended December 31, 2022 (the "Final Dividend"), the average of the median exchange rates of Hong Kong dollars to Renminbi as announced by the Foreign Exchange Trading Centre of the PRC for the calendar week preceding May 22, 2023, the date on which the resolution of payment of the Final Dividend was declared and passed (May 15, 2023 to May 19, 2023), was HKD 100 to RMB 89.1628. Accordingly, the Company will distribute the Final Dividend of HKD 1.1215 per ten share (tax inclusive) to the holders of the Company's H Shares. The Company will distribute the Final Dividend May 31, 2023.